Journal
ONCOGENE
Volume 24, Issue 17, Pages 2909-2915Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.onc.1208618
Keywords
cell cycle; cancer; development; cyclin; cdk; retinoblastoma; knockout
Funding
- NCI NIH HHS [CA085296, CA096527] Funding Source: Medline
- NIA NIH HHS [AG20208] Funding Source: Medline
- NIDCR NIH HHS [DE015302] Funding Source: Medline
Ask authors/readers for more resources
A fundamental aspect of cancer is dysregulated cell cycle control. Unlike normal cells that only proliferate when compelled to do so by developmental or other mitogenic signals in response to tissue growth needs, the proliferation of cancer cells proceeds essentially unchecked. This does not mean that cancer cell cycles are necessarily different from those found in normal cycling cells, but rather implies that cancer cells proliferate because they are no longer subject to proliferation- inhibitory influences arising from the stroma or from gene expression pattern changes consequent to 'terminal' differentiation, nor do they necessarily require extrinsic growth factors to recruit them into or maintain their proliferative state. Finally, cancer cells have also often avoided normal controls linked to cell cycle progression that halt proliferation in the presence of damaged DNA or other physiological insults. The result of these alterations is the inappropriate proliferation commonly associated with cancerous tumor formation. This review will summarize the current understanding of dysregulation of the G0/ G1- to- S- phase transition in cancer cells, with particular emphasis on recent in vivo studies that suggest a need to rethink existing models of cell cycle control in development and tumorigenesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available